The “i” has two important meanings. First, it represents the independence of the registry. Because the registry is managed by PERFUSE Study Group, a stand-alone clinical trial organization in Boston, and funded by SCAD Alliance, an independent nonprofit, the data generated and the research published will be unique. The research will not be influenced by any particular institution. A publications committee of iSCAD member principal investigators will oversee research project selection.